Abstract
Background: Normothermic Machine Perfusion (NMP) has been established in the field of solid organ transplantation for both liver and kidney allografts. The ability to perfuse organs at body temperature enables viability assessment as well as optimisation prior to implantation. Discussion: A recent in vitro report of the use of Mesenchymal Stem Cells (MSCs) in the use of a normothermic lung perfusion circuit has raised the possibility of their use in solid organ transplantation. The aim of this short review is to outline the potential uses of bone marrow derived MSCs for their use in renal allograft ex vivo NMP. An overview is provided of current literature of NMP as well as theorised uses for MSCs.
Highlights
Mesenchymal Stem Cells (MSCs) of bone marrow origin are a multipotent progenitor cells [1]
This review provides an overview of potential applications of MSCs with Normothermic Machine Perfusion (NMP) whilst theorising outcomes given
We have reviewed one study utilising human umbilical cord isolated MSCs to determine the potential challenges facing future use in solid organ transplantation
Summary
Normothermic Machine Perfusion (NMP) has been established in the field of solid organ transplantation for both liver and kidney allografts. The ability to perfuse organs at body temperature enables viability assessment as well as optimisation prior to implantation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have